Protocol for a feasibility and acceptability study for UK general population paediatric type 1 diabetes screening—the EarLy Surveillance for Autoimmune diabetes ( ELSA ) study

Quinn, Lauren M., Dias, Renuka P., Greenfield, Sheila M., Richter, Alex G., Garstang, Joanna, Shukla, David, Acharjee, Animesh, Gkoutos, Georgios, Oram, Richard, Faustini, Sian, Boiko, Olga, Litchfield, Ian, Boardman, Felicity, Zakia, Fatima, Burt, Christine, Connop, Clair, Lepley, Amanda, Gardner, Christine, Dayan, Colin ORCID: https://orcid.org/0000-0002-6557-3462, Barrett, Tim and Narendran, Parth 2024. Protocol for a feasibility and acceptability study for UK general population paediatric type 1 diabetes screening—the EarLy Surveillance for Autoimmune diabetes ( ELSA ) study. Diabetic Medicine , e15490. 10.1111/dme.15490

PDF - Published Version Available under License Creative Commons Attribution. Download (1MB)

Abstract

Aim: The EarLy Surveillance for Autoimmune (ELSA) study aims to explore the feasibility and acceptability of UK paediatric general population screening for type 1 diabetes. Methods: We aim to screen 20,000 children aged 3–13 years for islet‐specific autoantibodies through dried blood spot sample collection at home, hospital or community settings. Children with two or more autoantibodies are offered metabolic staging via oral glucose challenge testing. Feasibility assessments will compare recruitment modalities and uptake according to demographic factors (age, gender, ethnicity, level of deprivation and family history of diabetes) to determine optimal approaches for general population screening. The study is powered to identify 60 children (0.3%) with type 1 diabetes (stage 1–3). Parents are invited to qualitative interviews following ELSA completion (child screened negative or positive, single autoantibody or multiple, stage 1–3) to share their screening experience, strengths of the programme and any areas for improvement (acceptability assessments). Parents who decline screening or withdraw from participation are invited to interview to explore any concerns. Finally, we will interview professional stakeholders delivering the ELSA study to explore barriers and facilitators to implementation. Conclusion: Early detection of type 1 diabetes allows insulin treatment to be started sooner, avoids diagnosis as an emergency, gives families time to prepare and the opportunity to benefit from future prevention trials and treatments. ELSA will provide essential feasibility and acceptability assessments for UK general population screening to inform a future national screening programme for paediatric type 1 diabetes.

Item Type:	Article
Date Type:	Published Online
Status:	In Press
Schools:	Medicine
Additional Information:	License information from Publisher: LICENSE 1: URL: http://creativecommons.org/licenses/by/4.0/
Publisher:	Wiley
ISSN:	0742-3071
Date of First Compliant Deposit:	4 December 2024
Date of Acceptance:	18 November 2024
Last Modified:	04 Dec 2024 10:30
URI:	https://orca.cardiff.ac.uk/id/eprint/174485

Actions (repository staff only)

Edit Item